Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
deals
480 biomedical
abbvie
allergan
ally bridge group
alzheimer's disease
arsenal medical
big data analytics
blackrock
bob langer
casdin capital
chronic rhinosinusitis
covid-19
crispr
cynthia collins
diabetic nephropathy
drug delivery
editas medicine
eventide asset management
fda
focal segmental glomerulosclerosis
gene editing
genzyme
george whitesides
goldfinch bio
inflammation
investing
ipo
irving investors
jay ghosh
keros therapeutics
leber congenital amaurosis type 10
lyra therapeutics
What
biotech
3
×
company
genetic
ipo
medicines
million
new
raised
raises
abbvie
alliance
analysis
bio
bring
debut
develop
developing
diseases
drug
editas
editing
employing
exits
experimental
gene
goldfinch
kidney
late
later
lead
lyra
markets
nose
noses
pact
partnership
persistently
pruning
public
research
Language
unset
Current search:
biotech
×
boston
×
" clinical trials "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses